Zymosan is a well-known reagent prepared from yeast, Saccharomyces cerevisiae, and is composed primarily of bglucan, mannan, mannoprotein, and chitin.
) mice equally respond to Zymosan particles to induce proinflammatory cytokines comparable to wild-type macrophages, whereas macrophages from MyD88 Ϫ/Ϫ mice had decreased activity on the cytokine production in response to Zymosan. Furthermore, purified b-glucan particles derived from Zymosan showed no response in Dectin-1 Ϫ/Ϫ mouse-derived macrophages and bone marrow-derived dendritic cells. 9) These findings suggested that the parent Zymosan is a particulate bearing multiple-ligands for the receptors involved in macrophage activation, and is not adequate to investigate specific responses by the b-glucan recognition system. It has been reported that both Toll-like receptor (TLR)2 and TLR6 are required for the activation of nuclear factor (NF)-kB and the production of inflammatory cytokines such as tumor necrosis factor (TNF)-a by Zymosan particles and Zymosan enhances TLR2-mediated NF-kB activation on coexpression of TLR2 and Dectin-1. 10) The main components of Zymosan are b-glucans, 1) however, we already reported that the activity of crude Zymosan was polymyxin B-sensitive suggesting subtle contamination from lipopolysaccharides (LPS)-like substances.
11) Additionally, Zymosan has biologically active carbohydrate components other than b-glucan, for example, the binding of Zymosan to macrophages is inhibited by mannan, and Zymosan binds to the mannose receptor DC-SIGN. 12 ) Therefore, it is doubtful whether the active substances of Zymosan are mainly induced by b-glucan. In this study, to examine the active ingredients in Zymosan, we treated Zymosan particles with various kinds of solvents to wash away each active moiety. The ability of the Zymosan preparation to induce NFkB's activation in transfectants expressing innate immune receptors was examined. The washing process with organic solvents, including ethanol or chloroform/methanol, was effective at removing TLR2-reactive substances from the Zymosan without a loss of ability to bind Dectin-1 molecules. These Zymosan preparations are potent activators of novel NF-kB activation pathways using intracellular signaling molecules including CARD9 and Bcl10 in Dectin-1 transfec- tants. The results suggest that the response to TLR2 does not result from recognition of the b-glucan moiety of Zymosan, and that TLR2-ligands may be alcohol-removable or alcoholimmobilizable materials such as lipid-like molecules.
MATERIALS AND METHODS
Reagents Zymosan A and LPS were obtained from SIGMA. Pam 3 CSK 4 was purchased from EMC microcollections GmbH (Germany). schizophyllan (SPG) was purchased from Kaken Pharmaceutical Co. (Tokyo.,m Japan) Dextran T-500 was provided from Pharmacia.
Fractionation of Zymosan The Zymosan A preparation was suspended in endotoxin-free water and autoclaved. All procedures were performed using endotoxin-free injection water (Otsuka Pharmaceutical Co., Ltd., Japan). To prepare a water-insoluble fraction of Zymosan, Zymosan A (100 mg) was washed with 10 ml of pyrogen-free water and centrifuged, and the precipitate was collected. This procedure was repeated three times. The final precipitate was suspended in water and autoclaved, and used as the Zymosan water-insoluble fraction (ZWIS). Next, ZWIS was suspended with 30 ml of chloroform/methanol (2 : 1) or ethanol, and vigorously mixed by vortexing for 1 min, and centrifuged. The precipitate was resuspended with 30 ml of chloroform/ methanol or ethanol and mixed again. The procedure was repeated a total of three times. The final precipitate was washed with water, lyophilized, suspended in water, autoclaved, and used as the Zymosan chloroform/methanol-insoluble fraction (CMIS) or Zymosan ethanol-insoluble fraction (EtIS).
Cell Culture HEK293 cells (Cell Resource Center for Biomedical Research, Tohoku University) (2.5ϫ10 5 cells/ml) or HEK293T cells, kindly provided by Professor Kamei (Chiba University), were cultured in 96-well plates (Sumilon) in 100 ml of DMEM (SIGMA) supplemented with gentamicin sulfate (SIGMA, MO, U.S.A.) (50 mg/ml) containing 10% heat-inactivated fetal calf serum (FCS) at 37°C in humidified 5% CO 2 . The cells were stimulated with or without the Zymosan fraction for 6 h.
Luciferase Assays HEK 293 cells or HEK293T cells were transfected with the reporter gene plasmid using Lipofectamine 2000 (Invitrogen, OR, U.S.A.) in 96-well plates. In the experiment on TLR2-mediated NF-kB activation, each well received 25 ng of pELAM luciferase 13, 14) reporter and 2.5 ng of pRL-TK plasmid (Promega, WI, U.S.A.) transfection control reporter together with 25 ng TLR2, TLR4, MD-2, or CD14 expression vectors or p3xFLAG-CMV-9 (SIGMA) control vector, or 25 ng of the ELAM luciferase reporter and 2.5 ng RL-TK transfection control reporter together with 50 ng of the TLR2, the Dectin-1 expression vector, or p3xFLAG-CMV-14. In the case of CARD9/Bcl10-mediated NF-kB activation, Syk-transfected HEK293T cells were used. The pELAM luciferase vector was a gift from Dr. Golenbock (University of Massachusetts). TLR4 and CD14 were cloned into p3xFLAG-CMV-9, Dectin-1 was cloned into p3xFLAG-CMV-14, and TLR2 was cloned into pDisplay (Invitrogen). CARD9 and Bcl10 were cloned into p3xFLAG-CMV-14 and pBudCE4.1, respectively. Cells were incubated for 24 h after lipofection and stimulated with the indicated reagents for 6 h. The cells were lysed and firefly and Renilla luciferase activities were determined using a Dual Luciferase Assay kit (Promega). Luciferase activity is expressed as the ratio of ELAM luciferase (firefly) activity to RL-TK (Renilla) activity.
Analysis of Soluble CRD Binding to Zymosan Fractions Zymosan-derived fractions (100 mg) suspended in 100 ml of 50 mM Tris-buffered saline (pH 7.2) were incubated for 30 min at room temperature with 2 mg of soluble carbohydrate recognition domain (sCRD) of Dectin-1 obtained from the culture supernatant of a CHO-dhfr Ϫ transfectant (American Type Culture Collection), which was prepared by electroporation with an expression vector containing cDNA coding for the CRD of Dectin-1 and murine dehydrofolate reductase, in 100 ml of 2% FBS PBS. The particles were washed and incubated with 150 mg of FITC-conjugated anti-HA (SANTA CRUZ, U.S.A.) per ml for 30 min at room temperature. The particles were washed and fixed for 30 min at room temperature with neutral buffer (pH 7.0) containing 4% formaldehyde (Nakalai, Japan) and then subjected to a fluorescenceactivated cell sorting (FACS) analysis with FACSCalibur (BD Bioscience, CA, U.S.A.).
RESULTS

Preparation of Zymosan A-Derived Particles
Waterinsoluble Zymosan A particles (ZWIS) were further treated with chloroform/methanol or ethanol. The chloroform/ methanol-and ethanol-insoluble fractions were designated the chloroform/methanol-insoluble fraction, CMIS, and the ethanol insoluble fraction, EtIS. Saline was added to each fraction and autoclaved ( Fig. 1) . Each fraction was lyophilized and weighed before preparing suspension in saline. The yield of CMIS was 63.7%. That of EtIS was 72.7%.
Activation of NF-k kB via TLR2 and TLR4/MD-2/CD14 by Zymosan-Derived Fraction Pretreated with Polymyxin B To examine NF-kB activation by the Zymosan-derived fraction, HEK293 cells expressing TLRs were stimulated with the fraction and luciferase-assisted NF-kB activity in the cell was measured by reporter gene assay. We have already reported that Zymosan includes a polymyxin B-inhibitable substance which affects TLR4-mediated NF-kB activation.
11) Therefore, the reporter gene assay was performed in the absence or presence of polymyxin B to assess the effect of LPS-like substances on the Zymosan-derived fraction in the stimulation assay. Although ZWIS activated NF-kB in TLR2-or TLR4/MD-2/CD14-transfectants, CMIS and EtIS showed less activity than ZWIS (Fig. 2) . These results suggest that the active substance for TLR2-mediated NF-kB activation is removable or immobilizable by organic solvent treatment.
Ability of Dectin-1 to Bind the Zymosan-Derived Fraction It has been reported that Zymosan enhances TLR2-mediated activation of NF-kB on the coexpression of Dectin-1.
10) Dectin-1 is a specific receptor for b-glucan, and is thought to act by recognizing the b-glucan moiety in Zymosan to enhance the TLR2-mediated activity. To examine whether the b-glucan moiety in the Zymosan-derived fraction is accessible to Dectin-1, a HA-tagged soluble CRD (sCRD) of Dectin-1 was incubated with each Zymosan-derived preparation, and stained with fluorescein-labeled anti-HA antibody (Fig. 3) . The binding of ZWIS to the sCRD was decreased by coincubation with anti-Dectin-1 monoclonal antibody, 4B2 (Fig. 3A) .
15) The binding of sCRD to ZWIS (Fig. 3B) , CMIS (Fig. 3C) , and EtIS (Fig. 3D ) was observed by FACS with almost equal fluorescence intensity, implying each preparation has a similar ability to bind Dectin-1 molecules. It is suggested that the organic solvent does not prevent the b-glucans of Zymosan from binding to Dectin-1.
Enhancement of the Activation of NF-k kB via TLR2/Dectin-1 by ZWIS Was Blocked by Soluble 1,3-b bGlucan To examine whether Zymosan-enhanced NF-kB activity via TLR2 and Dectin-1 is dependent on b-glucanrecognition, pretreatment with a soluble 1,3-b-glucan, SPG, or soluble 1,6-a-glucan, Dextran T-500, of cells coexpressing TLR2 and Dectin-1 stimulated by ZWIS was performed (Fig.  4) . TLR2-mediated NF-kB activation on the coexpression of TLR2 and Dectin-1 was reduced by pretreatment with SPG but not Dextran T-500. These results suggested that 1,3-bglucan in ZWIS enhanced TLR2-mediated NF-kB activation via Dectin-1. how Dectin-1 contributes to the TLR2-mediated NF-kB activation in the transfectant, HEK293 cells coexpressing TLR2 and the Dectin-1 mutant were stimulated by the Zymosan-derived fraction and luciferase-assisted NF-kB activation in the cell was measured by reporter gene assay (Fig. 5) . Wild-type Dectin-1 and TLR2-transduced cells showed higher NF-kB activation than TLR2-transduced cells on stimulation with ZWIS. However, CMIS and EtIS only slightly activated the wild-type Dectin-1 and TLR2-transduced cells. Transduction of the Dectin-1 mutant did not increase the TLR2-mediated NF-kB activation by ZWIS, CMIS, and EtIS. These results suggested that the organic solvent-treatment effectively reduced the TLR2-mediated NF-kB activation.
Enhancement of NF-k kB
Effect of Zymosan-Derived Preparations on Dectin-1/CARD9/Bcl10-Mediated NF-k kB Activation Recently, it has been demonstrated that Dectin-1/Syk act as signaling receptors by which intracellular adaptor molecules, CARD9
and Bcl10, can transduce the signals for NF-kB activation. 16) To examine whether the Zymosan preparations are able to stimulate the CARD9/Bcl10 pathway, HEK293T cells were transduced with expression vectors containig Syk tyrosine kinase, CARD9, Bcl10, and/or Dectin-1, and stimulated with the Zymosan-derived particles. The activation of NF-kB assessed by measuring luciferase activity was increased by each Zymosan-derivative in a dose-dependent manner (Fig.  6) . However, the CARD9/Bcl10 transfectant showed no increase in activity in the absence of Dectin-1 in any preparations even at a higher dose. These results suggest that the Zymosan preparations, such as ZWIS, CMIS, and EtIS, are biologically active ligands for Dectin-1 in the activation of NF- 16 Vol. 31, No. 1 kB via the CARD9/Bcl10 signaling pathway even in the absence of TLR2.
DISCUSSION
Zymosan has long been used as a reagent for inducing inflammatory responses. [2] [3] [4] [5] [6] Zymosan activates leukocytes to produce various cytokines, however, we have already reported that it contains a LPS-like substance which is inhibitable with polymyxin B. 10) We have demonstrated in the present study that the chloroform/methanol or ethanol-insoluble element of Zymosan had no effect on the activation of NF-kB in TLR2 transfectants, whereas Water-washed Zymosan particles, ZWIS, showed TLR2-mediated NF-kB activity. It has been reported that TLR2 is required for the activation of NF-kB and the production of TNF-a by Zymosan particles. 17) Additionally, the activity of mycoplasmal macrophage-activating lipopeptide 2 (MALP-2) is mediated via TLR2.
18) MALP-2 was extracted with chloroform/ methanol from Mycoplasma fermentans. 19) Since the NF-kB activity of ZWIS was diminished by treatment with such an organic solvent, it is suggested that the TLR mediated-active moiety of Zymosan is removed or inactivated by chloroform/methanol or ethanol treatment. Since the treatment with chloroform/methanol has been widely used for extensive extracting lipid substances from the natural products, 20) chloroform/methanol treatment might be more efficient to remove lipid-like TLR2-ligands than ethanol-treatment.
Dectin-1 is a specific receptor for 1,3-b-glucans. It was reported that Dectin-1 binds to b-glucan and internalizes Zymosan and Candida albicans containing b-glucan, 8) and Dectin-1-mediated internalization of yeast particles required tyrosine phosphorylation and a cytoplasmic immunoreceptor tyrosine-based activation motif (ITAM)-like amino acid sequence.
21) The Zymosan-derived fraction bound to sCRD (Fig. 3) and we have already reported that Dectin-1 can bind 1,3-b-glucans and the binding was influenced by the replacement of Trp-Ile-His residues in CRD, 15) indicating that the Zymosan-derived fraction has b-glucan. ZWIS enhanced Dectin-1 and TLR2-mediated NF-kB activity more than TLR2 alone and this enhancement was reduced by pretreatment with soluble 1,3-b-glucan (Fig. 4) . However, CMIS and EtIS only slightly enhance Dectin-1 and TLR2-mediated NFkB activity. Additionally, mutation of the Trp 221 and His 223 of Dectin-1 did not enhance TLR2-mediated NF-kB activity (Fig. 6) . Furthermore, Dectin-1 reportedly enhanced the expression of IL-12 mRNA in combination with lipopeptide, a TLR2 ligand, and a b-glucan-enriched Zymosan fraction, 10) and stimulated production of proinflammatory cytokines by a pathogenic fungus, Coccidioides posadasii. 22) These findings suggest that the substance treated with the organic solvent, which may be a b-glucan-rich component, can not activate NF-kB via TLR, but it can be recognized by CRD of Dectin-1 and enhance TLR2-mediated NF-kB activation via CRD. Dectin-1 is expressed on phagocytic cells and mediates the internalization and biological activity of b-glucan. 10, 23) 1,3-bGlucan is contained in microbes especially the fungal cell wall. In addition, 1,3-b-glucans have various biological activities which depend on their physicochemical properties, such as molecular weight, conformation, and solubility. [24] [25] [26] Zymosan induces some biological activity in phagocytes, such as cytokine production and TLR-mediated NF-kB activity, however, we demonstrated that none of these activities are induced by b-glucan alone. In this study, we demonstrated that Zymosan treated with chloroform/methanol or ethanol as an organic solvent could not induce TLR-mediated NF-kB activity, suggesting that the TLR-mediated NFkB activity of Zymosan is not induced by b-glucan. We already reported that Candida albicans-oxidized particles containing 1,3-b-glucan, OX-CA, induced TNF-a production in RAW264.7.
27) The TNF-a inducing activity of the b-glucans was also dependent on the ultrastructure in the physiological condition. 27) Although soluble 1,3-b-glucan, SPG, has an ability to bind Dectin-1, stimulatory effects on phagocytes were not induced or quite lower than particulate 1,3-b-glucans in vitro. Similar results were reported in several literatures using other soluble 1,3-b-glucans. [24] [25] [26] However, the specificity of the physical state of b-glucan has not been analyzed at the receptor level, including receptor clustering on the cell surface. Further studies are needed to clarify the specificity of both Dectin-1 and b-glucan, whereby various biological activities of b-glucan may be elucidated. TLR2-mediated NF-kB activation with Zymosan is not induced by b-glucan and the Zymosan-derived LPS-like or unidentified substance.
We have also examined the response of the CARD9/Bcl10 pathway in the Dectin-1-mediated activation of NF-kB on stimulation with Zymosan preparations. CARD9 operates as a key adaptor for non-TLR pattern recognition receptor (PRR) signal transduction, which is required to link the activation of Dectin-1/Syk with the Bcl10-Malt1-dependent activation of NF-kB for innate anti-fungal immunity.
16) The HEK293T cells transfected with these signaling molecules showed significant increased NF-kB activity on stimulation not only with ZWIS but also with non-TLR2 ligands, CMIS and EtIS, suggesting these preparations act as non-TLR PRR stimuli via a Dectin-1 intrinsic pathway in the presence of CARD9/Bcl10.
A number of studies concerning activation mechanisms in the innate immune-system have been performed in recent years. The ligands from microbial products for PRRs tend to contain various agonists as reported in the case of lipoprotein contamination even in commercially available LPS preparations. 28, 29) These risks may also apply when studying the innate immune response to fungal products. Several reports have described a requirement of TLR2 or TLR4 for the activation of macrophage in response to Aspergillus fumigatus, Candida albicans, and Coccidioides posadasii, 30, 31) although the active ligands for TLRs remain to be determined. Two recent reports using Dectin-1 Ϫ/Ϫ mice described different outcomes of the deficiency of Dectin-1 in response to Zymosan. Brown and colleagues found a significant inability of the Dectin-1 Ϫ/Ϫ macrophages to engage in Zymosan-induced inflammatory cytokine production, 32) whereas Iwakura and colleagues indicated that the Dectin-1 deficiency has no effect on the production of cytokines in response to Zymosan, but in a complete reduction on stimulation with a b-glucan-enriched Zymosan derivative. 9) These findings may suggest that Zymosan preparations have lot-to-lot variation in the content of active materials. To examine the innate immune response to fungal b-glucans, it is indispensable to remove TLR-ligands such as those for TLR2 and TLR4 from the fungal preparations. The present study might provide suggestions regarding a simple procedure to reduce the TLR2-and TLR4-mediated innate immune response to fungal insoluble materials.
